Results 121 to 130 of about 5,500,616 (251)

Antiviral Therapy in Patients after Treatment for Hepatitis C-Related Hepatocellular Carcinoma

Gut and Liver, 2011
Background/Aims: Despite great progress, antiviral treatment for chronic hepatitis C in patients with prior hepatocellular carcinoma (HCC) has been rarely investigated.
doaj   +1 more source

Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions

Portal Hypertension &Cirrhosis, EarlyView.
This review systematically summarizes a full spectrum of non‐invasive diagnostic approaches for portal hypertension (PH), including imaging modalities, elastography, serum biomarkers, composite scoring systems and endoscopic ultrasound‐guided portal pressure gradient (EUS‐PPG), and analyzes their performance across different liver disease etiologies ...
Lijia Yin, Huikuan Chu, Ling Yang
wiley   +1 more source

Experience of combination antiviral therapy for chronic hepatitis c in HIV-infected patients in the Novgorod region

RUDN Journal of Medicine, 2014
The paper presents an analysis of effectiveness of antiviral therapy for chronic hepatitis C in HIV-infected patients, factors affecting the achievement of sustained virologic response are revealed.
O V Azovtzeva, S A Buzunova, G S Arkhipov, E I Arkhipova, T S Trofimova   +4 more
doaj  

Thyroid dysfunction in Turkish patients with chronic hepatitis C receiving peginterferon plus ribavirin in the period of 2005-2010

Brazilian Journal of Infectious Diseases
Interferon-α based therapy for chronic hepatitis C (CHC) is associated with thyroiditis and thyroid dysfunction (TD). This study investigated whether TD during pegylated interferon-a (PEG-IFN) plus ribavirin treatment favors sustained viral response (SVR)
Sener Barut, Ozgur Gunal, Unal Erkorkmaz, Feyza Yildiz   +3 more
doaj   +1 more source

Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B

, 2010
The reported durability of virologic response after successful lamivudine monotherapy is variable, and the question remains as to whether virologic responses can be maintained over an extended follow-up period.
이현웅, 안상훈, 이관식, 박준용, 김도영, 한광협, 전재윤, 백용한   +7 more
core   +1 more source

Advances in Viral Markers for Predicting Functional Cure of Chronic Hepatitis B

Portal Hypertension &Cirrhosis, EarlyView.
Functional cure, defined as sustained hepatitis B surface antigen (HBsAg) loss, is achieved by only a minority of patients with chronic hepatitis B (CHB); early identification of likely responders may improve cure rates and reduce costs. However, responses to antiviral therapy vary considerably, necessitating reliable hepatitis B virus (HBV) viral ...
Xinrong Lu, Xin Yang, Qishui Ou, Zhen Xun   +3 more
wiley   +1 more source

Univariate and multivariate analysis to identify factors associated with sustained virologic response 12 weeks after scheduled end of therapy (SVR12).

, 2015
AOR: adjusted odds ratio; CI: confidence interval; IL28B: interleukin 28B.±available in 100 patients receiving TVR and 42 subject receiving BOC;¶as referred to dual therapy with peg-IFN plus RBV.Univariate and multivariate analysis to identify factors ...
Karin Neukam (584773), Mattias Mandorfer (584776), Manuel Márquez (731763), Thomas Lutz (420561), Antonio Rivero-Juárez (299565), Sanjay Bhagani (300128), Juergen K. Rockstroh (731766), Annette Haberl (731761), Stefan Mauss (143062), Marcial Delgado (731765), Jan Fehr (174310), Ignacio de los Santos-Gil (731764), Marcel Stoeckle (731762), Antonio Collado (464581), Luis F. López-Cortés (189634), Antonio Rivero (189661), Daniela I. Munteanu (731760), Stefan Scholten (210941), Juan A. Pineda (189667)   +18 more
core   +1 more source

Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 420-434, March 2025.
ABSTRACT Chronic Hepatitis B presents a significant health and socioeconomic burden. The risk of hepatocellular carcinoma remains elevated although treatments are available. Achieving an optimal treatment regimen necessitates a deep comprehension of the dynamic relationship between the virus and its host across disease states.
Clémence Boivin‐Champeaux, Nieves Velez de Mendizabal, Aksana Jones, Scott Balsitis, Stephan Schmidt, Justin S. Feigelman, Francine Johansson Azeredo   +6 more
wiley   +1 more source

Monitoring the Evolution of Portal Hypertension After Sustained Virologic Response [PDF]

Gastroenterology, 2018
Mattias Mandorfer, Thomas Reiberger, Markus Peck-Radosavljevic   +2 more
openaire   +2 more sources

Assessment of Oxidative Stress, Vitellogenin, and Human Health Risks Derived From Nile Tilapia Exposed to Metals and Metalloids in Southeastern Brazil

Environmental Toxicology, EarlyView.
ABSTRACT Urban coastal lagoons are highly vulnerable ecosystems increasingly affected by metal contamination, as well as multiple anthropogenic stressors. This study evaluated ecotoxicological and human health risks associated with chronic metal exposure in Nile tilapia (Oreochromis niloticus) from an anthropogenically impacted lagoon in southeastern ...
Julia Araújo Alves, Priscila M. O. Muniz Cunha, Shênia Patrícia Corrêa Novo, Lorena Oliveira Souza Soares, Tatiana Dillenburg Saint‐Pierre, Fábio Veríssimo Correia, André Luís de Sá Salomão, Rachel Ann Hauser‐Davis, Enrico Mendes Saggioro   +8 more
wiley   +1 more source